

Oceania Healthcare lifts FY25 earnings on sales momentum, strategic reset underway
NZX-listed Oceania Healthcare has reported an underlying EBITDA of $86.0 million for the year ended 31 March 2025, a 4.1% increase on FY24, driven by steady sales momentum and an accelerated sell-down of stock. Sales volumes for FY25 reached 520...